Andrew is a highly experienced Global Market Access expert, leading pragmatic, solution focussed consultancy services at Initiate, a best-in-class consultancy with exceptional experience in the rare disease sector.
Having gained initial experience in field-based and market-access commercial roles, his career moved into senior management roles leading HTA submissions, pricing and reimbursement projects, Value Dossier development, and Value Communication across global markets.
Andrew has a unique set of experience, developing and implementing access initiatives with a particular focus on launching new products in the rare disorder arena. His focus is primarily to ensure clinical demand, value demonstration, and acceptance by the payer customer group independent of their market, data set, and belief.